The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test, a companion diagnostic for the cancer drug Tarceva (erlotinib). This is the first FDA-approved companion diagnostic that detects epidermal growth factor receptor (EGFR) gene mutations, which are present in approximately 10 percent of non-small cell lung cancers (NSCLC). Food and Drug Administration–Press [...]
Read More...Categories
FDA Recalls
- This feed (or Twitter.com) is having issues at this time, please check back later.
FDA Drug Info
- This feed (or Twitter.com) is having issues at this time, please check back later.
FDA Medical Device
- This feed (or Twitter.com) is having issues at this time, please check back later.
FDA Medication Watch
- This feed (or Twitter.com) is having issues at this time, please check back later.
Tags
Alert Alerts Allergy announces approves Because Brand cancer Certain Class Communication Consumer Contamination Dietary Drug Drugs Feed first food Foods from Health Inc. Ingredient Injection Issues Mediation Medical Milk Nationwide Possible Potential Press product Products Recall Recalls Releases Risk Safety treat Undeclared Voluntarily Voluntary Watch